Please Wait.....
Report
MEA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 220 Pages I Data Bridge Market Research
Middle East and Africa colorectal cancer diagnostics market is projected to register a substantial CAGR of 6.9% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
Middle East and Africa Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030
Some of the factors that can affect the growth of the market are:
- Rise in healthcare expenditure for cancer diagnosis and treatment
- Novel technological advancements in cancer diagnostics
Market Players:
The key market players in Middle East and Africa colorectal cancer diagnostics market are listed below:
- Koninklijke Philips N.V.
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- FUJIFILM Corporation
- Agilent Technologies, Inc.
- BD
- General Electric Company
- Siemens Healthcare GmbH
- Abbott
- Neusoft Corporation
- BioFire Diagnostics
- QIAGEN
- Hologic, Inc.
- PlexBio
- GE HealthCare.
TABLE OF CONTENTS
1 INTRODUCTION 43
1.1 OBJECTIVES OF THE STUDY 43
1.2 MARKET DEFINITION 43
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET 43
1.4 LIMITATIONS 45
1.5 MARKETS COVERED 45
2 MARKET SEGMENTATION 48
2.1 MARKETS COVERED 48
2.2 GEOGRAPHICAL SCOPE 49
2.3 YEARS CONSIDERED FOR THE STUDY 50
2.4 CURRENCY AND PRICING 50
2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT TYPE LIFELINE CURVE 54
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
2.9 DBMR MARKET POSITION GRID 56
2.10 MARKET END USER COVERAGE GRID 57
2.11 VENDOR SHARE ANALYSIS 58
2.12 SECONDARY SOURCES 59
2.13 ASSUMPTIONS 59
3 EXECUTIVE SUMMARY 60
4 PREMIUM INSIGHTS 63
4.1 PORTER'S FIVE FORCES 64
4.2 PESTEL ANALYSIS 65
5 INDUSTRY INSIGHTS: 66
6 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 67
6.1 REGULATORY SCENARIO IN THE U.S 67
6.2 REGULATORY SCENARIO IN AUSTRALIA 67
6.3 REGULATORY SCENARIO IN JAPAN 68
6.4 REGULATORY SCENARIO IN CHINA 68
7 MARKET OVERVIEW 70
7.1 DRIVERS 72
7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 72
7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 72
7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 72
7.2 RESTRAINTS 73
7.2.1 STRINGENT REGULATORY POLICIES 73
7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 73
7.3 OPPORTUNITIES 74
7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 74
7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 75
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 75
7.4 CHALLENGES 76
7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 76
7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 77
8 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 78
8.1 OVERVIEW 79
8.2 INSTRUMENTS 82
8.2.1 PATHOLOGY-BASED INSTRUMENTS 83
8.2.1.1 PCR INSTRUMENTS 83
8.2.1.2 SLIDE STAINING SYSTEMS 83
8.2.1.3 TISSUE PROCESSING SYSTEMS 84
8.2.1.4 CELL PROCESSORS 84
8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 84
8.2.2 IMAGING INSTRUMENTS 84
8.2.2.1 ULTRASOUND SYSTEMS 84
8.2.2.2 CT SYSTEMS 84
8.2.2.3 MRI SYSTEMS 85
8.2.2.4 OTHERS 85
8.2.3 BIOPSY INSTRUMENTS 85
8.2.4 OTHERS 85
8.3 CONSUMABLES & ACCESSORIES 85
8.3.1 KITS 86
8.3.1.1 PCR KITS 86
8.3.1.2 DNA POLYMERASE KITS 86
8.3.1.3 NUCLEIC ACID ISOLATION KITS 86
8.3.1.4 OTHERS 87
8.3.2 REAGENTS 87
8.3.2.1 ASSAYS 87
8.3.2.2 BUFFERS 87
8.3.2.3 PRIMERS 87
8.3.2.4 OTHERS 87
8.3.3 OTHER CONSUMABLES 87
9 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 88
9.1 OVERVIEW 89
9.2 STOOL EXAMINATION 92
9.3 BLOOD TEST 92
9.3.1 COMPLETE BLOOD COUNT (CBC) 93
9.3.2 TUMOR MARKER TEST 94
9.3.3 LIVER ENZYME BLOOD TEST 94
9.4 IMAGING TEST 94
9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 95
9.4.2 MRI 95
9.4.3 ULTRASOUND 95
9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 96
9.4.5 OTHERS 96
9.5 TUMOR MARKERS 96
9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 97
9.5.2 CA19-9 BIOMARKER TEST 97
9.5.3 CA 50 MARKER TEST 97
9.5.4 OTHERS 97
9.6 BIOPSY 97
9.7 OTHERS 98
10 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 99
10.1 OVERVIEW 100
10.2 STAGE III 103
10.3 STAGE IV 103
10.4 STAGE II 104
10.5 STAGE I 105
10.6 STAGE 0 105
11 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 107
11.1 OVERVIEW 108
11.2 GERIATRIC 111
11.3 ADULTS 111
11.4 PEDIATRIC 112
12 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 114
12.1 OVERVIEW 115
12.2 ADENOCARCINOMA 118
12.3 COLORECTAL LYMPHOMA 118
12.4 GASTROINTESTINAL STROMAL TUMORS 119
12.5 CARCINOID TUMORS 120
12.6 OTHERS 120
13 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 122
13.1 OVERVIEW 123
13.2 HOSPITALS 126
13.3 DIAGNOSTIC CENTERS 126
13.4 CANCER RESEARCH CENTERS 127
13.5 AMBULATORY SURGICAL CENTERS 128
13.6 ACADEMIC INSTITUTES 128
13.7 OTHERS 129
14 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION 131
14.1 MIDDLE EAST AND AFRICA 132
14.1.1 SOUTH AFRICA 142
14.1.2 SAUDI ARABIA 147
14.1.3 U.A.E. 152
14.1.4 EGYPT 157
14.1.5 ISRAEL 162
14.1.6 REST OF MIDDLE EAST AND AFRICA 167
15 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 168
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 168
16 SWOT ANALYSIS 169
17 COMPANY PROFILE 170
17.1 F. HOFFMANN- LA ROCHE LTD 170
17.1.1 COMPANY SNAPSHOT 170
17.1.2 REVENUE ANALYSIS 170
17.1.3 COMPANY SHARE ANALYSIS 171
17.1.4 PRODUCT PORTFOLIO 171
17.1.5 RECENT DEVELOPMENT 171
17.2 KONINKLIJKE PHILIPS N.V. 172
17.2.1 COMPANY SNAPSHOT 172
17.2.2 REVENUE ANALYSIS 172
17.2.3 COMPANY SHARE ANALYSIS 173
17.2.4 PRODUCT PORTFOLIO 173
17.2.5 RECENT DEVELOPMENT 173
17.3 THERMO FISHER SCIENTIFIC INC. 175
17.3.1 COMPANY SNAPSHOT 175
17.3.2 REVENUE ANALYSIS 175
17.3.3 COMPANY SHARE ANALYSIS 176
17.3.4 PRODUCT PORTFOLIO 176
17.3.5 RECENT DEVELOPMENT 176
17.4 ILLUMINA, INC. 177
17.4.1 COMPANY SNAPSHOT 177
17.4.2 REVENUE ANALYSIS 177
17.4.3 COMPANY SHARE ANALYSIS 178
17.4.4 PRODUCT PORTFOLIO 178
17.4.5 RECENT DEVELOPMENT 178
17.5 QUEST DIAGNOSTICS INCORPORATED 179
17.5.1 COMPANY SNAPSHOT 179
17.5.2 REVENUE ANALYSIS 179
17.5.3 COMPANY SHARE ANALYSIS 180
17.5.4 PRODUCT PORTFOLIO 180
17.5.5 RECENT DEVELOPMENT 180
17.6 ABBOTT 181
17.6.1 COMPANY SNAPSHOT 181
17.6.2 REVENUE ANALYSIS 181
17.6.3 PRODUCT PORTFOLIO 182
17.6.4 RECENT DEVELOPMENT 182
17.7 AGILENT TECHNOLOGIES, INC. 183
17.7.1 COMPANY SNAPSHOT 183
17.7.2 REVENUE ANALYSIS 183
17.7.3 PRODUCT PORTFOLIO 184
17.7.4 RECENT DEVELOPMENT 184
17.8 BD 185
17.8.1 COMPANY SNAPSHOT 185
17.8.2 REVENUE ANALYSIS 185
17.8.3 PRODUCT PORTFOLIO 186
17.8.4 RECENT DEVELOPMENT 186
17.9 BEIJING O&D BIOTECH CO., LTD. 187
17.9.1 COMPANY SNAPSHOT 187
17.9.2 PRODUCT PORTFOLIO 187
17.9.3 RECENT DEVELOPMENT 187
17.10 BIOFIRE DIAGNOSTICS 188
17.10.1 COMPANY SNAPSHOT 188
17.10.2 REVENUE ANALYSIS 188
17.10.3 PRODUCT PORTFOLIO 189
17.10.4 RECENT DEVELOPMENT 189
17.11 BIO-RAD LABORATORIES, INC. 190
17.11.1 COMPANY SNAPSHOT 190
17.11.2 REVENUE ANALYSIS 190
17.11.3 PRODUCT PORTFOLIO 191
17.11.4 RECENT DEVELOPMENT 191
17.12 CANON MEDICAL SYSTEMS CORPORATION. 192
17.12.1 COMPANY SNAPSHOT 192
17.12.2 REVENUE ANALYSIS 192
17.12.3 PRODUCT PORTFOLIO 193
17.12.4 RECENT DEVELOPMENT 193
17.13 FONAR CORP. 194
17.13.1 COMPANY SNAPSHOT 194
17.13.2 REVENUE ANALYSIS 194
17.13.3 PRODUCT PORTFOLIO 195
17.13.4 RECENT DEVELOPMENT 195
17.14 FUJIFILM CORPORATION 196
17.14.1 COMPANY SNAPSHOT 196
17.14.2 REVENUE ANALYSIS 196
17.14.3 PRODUCT PORTFOLIO 197
17.14.4 RECENT DEVELOPMENT 197
17.15 GE HEALTHCARE. 198
17.15.1 COMPANY SNAPSHOT 198
17.15.2 REVENUE ANALYSIS 198
17.15.3 PRODUCT PORTFOLIO 199
17.15.4 RECENT DEVELOPMENT 199
17.16 HOLOGIC, INC. 200
17.16.1 COMPANY SNAPSHOT 200
17.16.2 REVENUE ANALYSIS 200
17.16.3 PRODUCT PORTFOLIO 201
17.16.4 RECENT DEVELOPMENT 201
17.17 MEDONICA CO. LTD 202
17.17.1 COMPANY SNAPSHOT 202
17.17.2 PRODUCT PORTFOLIO 202
17.17.3 RECENT DEVELOPMENT 202
17.18 MERCK KGAA 203
17.18.1 COMPANY SNAPSHOT 203
17.18.2 REVENUE ANALYSIS 203
17.18.3 PRODUCT PORTFOLIO 204
17.18.4 RECENT DEVELOPMENT 204
17.19 MINFOUND MEDICAL SYSTEMS CO., LTD 205
17.19.1 COMPANY SNAPSHOT 205
17.19.2 PRODUCT PORTFOLIO 205
17.19.3 RECENT DEVELOPMENT 205
17.20 MYRIAD GENETICS, INC. 206
17.20.1 COMPANY SNAPSHOT 206
17.20.2 REVENUE ANALYSIS 206
17.20.3 PRODUCT PORTFOLIO 207
17.20.4 RECENT DEVELOPMENT 207
17.21 NEUSOFT CORPORATION 208
17.21.1 COMPANY SNAPSHOT 208
17.21.2 REVENUE ANALYSIS 208
17.21.3 PRODUCT PORTFOLIO 209
17.21.4 RECENT DEVELOPMENT 209
17.22 PLEXBIO 210
17.22.1 COMPANY SNAPSHOT 210
17.22.2 PRODUCT PORTFOLIO 210
17.22.3 RECENT DEVELOPMENT 210
17.23 QIAGEN 211
17.23.1 COMPANY SNAPSHOT 211
17.23.2 REVENUE ANALYSIS 211
17.23.3 PRODUCT PORTFOLIO 212
17.23.4 RECENT DEVELOPMENT 212
17.24 SIEMENS HEALTHCARE GMBH 213
17.24.1 COMPANY SNAPSHOT 213
17.24.2 REVENUE ANALYSIS 213
17.24.3 1.2.3 PRODUCT PORTFOLIO 214
17.24.4 RECENT DEVELOPMENT 214
17.25 STERNMED GMBH 215
17.25.1 COMPANY SNAPSHOT 215
17.25.2 PRODUCT PORTFOLIO 215
17.25.3 RECENT DEVELOPMENT 215
17.26 TIME MEDICAL HOLDING. 216
17.26.1 COMPANY SNAPSHOT 216
17.26.2 PRODUCT PORTFOLIO 216
17.26.3 RECENT DEVELOPMENT 216
18 QUESTIONNAIRE 217
19 RELATED REPORTS 220
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security